Discover the in’s and out’s of our solutions in a private demo
Papua New Guinea
Tuberculosis remains a major public health challenge in Papua New Guinea, placing significant pressure on the health system. The country continues to face high rates of TB, including drug-resistant forms of the disease, while TB-HIV co-infection further complicates diagnosis, treatment, and control efforts.
45,000 people
developed TB in 2023
3,200 people
died from the disease
2,500 individuals
co-infected with HIV
2,200 cases
of drug-resistant TB
Our work in Papua New Guinea
To support national screening efforts, we’ve worked closely with
local and international partners since 2016.
2016
We delivered a Delft OneStopTB X-ray Clinic to the World Health Organization (WHO), fitted with an ultra-portable digital X-ray system and CAD4TB. This unit enabled point-of-care diagnostics in harder-to-reach areas.
2019
We provided 2 Delft OneStopTB X-ray Clinics through UNOPS, each equipped with an EasyDR system and CAD4TB.
2021
We provided 3 Delft OneStopTB X-ray Clinics, each installed with a CompassDR and CAD4TB, also through UNOPS.
2022
We continued to strengthen the diagnostic capacity in 2022 by supplying an additional CAD4TB to the nation.
2024
We delivered 2 Delft Light systems with CAD4TB to the Ministry of Health to support broader access to TB screening nationwide.
2025
We provided 4 Delft Light, each equipped with 4 CAD4TB, to the National TB Programme. In the same year, the Burnet MacFarlane Institute acquired a CAD4TB in the country.
Making a difference
Press coverage
Article
In the News: Papua New Guinea
Research papers
Article
Evidence from the Field: Papua New Guinea
Watch the video to see our impact in action.
Connect with our representative in your country.
We work alongside Ministries of Health, implementing partners, and healthcare providers to ensure solutions are aligned with national strategies and local healthcare systems.
Mike Rosenmöller
- Review which solutions align with your programmatic and operational needs
- Explore partnership opportunities and long-term collaboration
- Address technical, clinical, and infrastructure considerations specific to your setting